Extracellular matrix remodelling: the role of matrix metalloproteinases
暂无分享,去创建一个
[1] Koichi Hattori,et al. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases , 2003, Current opinion in hematology.
[2] Peter Friedl,et al. Compensation mechanism in tumor cell migration , 2003, The Journal of cell biology.
[3] William C. Parks,et al. Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury , 2002, Cell.
[4] Pedro Romero,et al. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity , 2002, Oncogene.
[5] S. Rafii,et al. Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.
[6] D. Sheppard,et al. The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP–dependent activation of TGF-β1 , 2002, The Journal of cell biology.
[7] Y. Hegerfeldt,et al. Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies. , 2002, Cancer research.
[8] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[9] A. Strongin,et al. Processing of Integrin αv Subunit by Membrane Type 1 Matrix Metalloproteinase Stimulates Migration of Breast Carcinoma Cells on Vitronectin and Enhances Tyrosine Phosphorylation of Focal Adhesion Kinase* , 2002, The Journal of Biological Chemistry.
[10] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[11] I. Stamenkovic,et al. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. , 2002, Genes & development.
[12] R. Sedláček,et al. Matrix Metalloproteinase-19 Is Expressed in Myeloid Cells in an Adhesion-Dependent Manner and Associates with the Cell Surface1 , 2002, The Journal of Immunology.
[13] David B. Alexander,et al. The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis , 2001, Cell.
[14] C. Overall,et al. Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.
[15] R. Hynes,et al. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[16] Juan P. Albar,et al. Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling* , 2001, The Journal of Biological Chemistry.
[17] P. E. Van den Steen,et al. Gelatinase B: a tuner and amplifier of immune functions. , 2001, Trends in immunology.
[18] L. Matrisian,et al. Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.
[19] R. Flavell,et al. Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells , 2001, Nature Medicine.
[20] Allan Balmain,et al. TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.
[21] M. Shipp,et al. Stromelysin‐3 suppresses tumor cell apoptosis in a murine model * , 2001, Journal of cellular biochemistry.
[22] Jingsong Xu,et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo , 2001, The Journal of cell biology.
[23] T. Stricker,et al. Pro-collagenase-1 (Matrix Metalloproteinase-1) Binds the α2β1 Integrin upon Release from Keratinocytes Migrating on Type I Collagen* , 2001, The Journal of Biological Chemistry.
[24] A. Rosemurgy,et al. Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] H. Shimada,et al. Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide. , 2001, Journal of experimental & clinical cancer research : CR.
[26] H. Mori,et al. Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration , 2001, The Journal of cell biology.
[27] J. Quigley,et al. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. , 2001, Blood.
[28] Po-Huang Lee,et al. Aspirin inhibits matrix metalloproteinase-2 activity, increases E-cadherin production, and inhibits in vitro invasion of tumor cells. , 2001, Biochemical and biophysical research communications.
[29] S. Arii,et al. Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance , 2001, Cancer.
[30] P. Bornstein,et al. Extracellular Matrix Metalloproteinase 2 Levels Are Regulated by the Low Density Lipoprotein-related Scavenger Receptor and Thrombospondin 2* , 2001, The Journal of Biological Chemistry.
[31] I. Goldberg,et al. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. , 2001, Cancer research.
[32] C. Sautès-Fridman,et al. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. , 2001, Cancer research.
[33] T. Mcclanahan,et al. Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.
[34] Jeffrey W. Smith,et al. MT1-MMP Initiates Activation of pro-MMP-2 and Integrin αvβ3 Promotes Maturation of MMP-2 in Breast Carcinoma Cells , 2001 .
[35] M. Hidalgo,et al. Development of matrix metalloproteinase inhibitors in cancer therapy. , 2001, Journal of the National Cancer Institute.
[36] H. Moon,et al. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. , 2001, Cancer research.
[37] D. Boger,et al. Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[39] I. Stamenkovic,et al. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. , 2001, Cancer research.
[40] M. Mareel,et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. , 2001, Journal of cell science.
[41] B. Sheu,et al. A novel role of metalloproteinase in cancer-mediated immunosuppression. , 2001, Cancer research.
[42] U. Felbor,et al. Generation and degradation of human endostatin proteins by various proteinases , 2000, FEBS letters.
[43] G. Fuller,et al. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. , 2000, Cancer research.
[44] I. Stamenkovic. Matrix metalloproteinases in tumor invasion and metastasis. , 2000, Seminars in cancer biology.
[45] D. Hanahan,et al. MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.
[46] M. Simons,et al. Thrombospondin Type 1 Repeats Interact with Matrix Metalloproteinase 2 , 2000, The Journal of Biological Chemistry.
[47] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[48] K. W. Kim,et al. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. , 2000, Cancer research.
[49] H. Granger,et al. The heparin binding 25 kDa fragment of thrombospondin‐1 promotes angiogenesis and modulates gelatinase and TIMP‐2 production in endothelial cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] P. Soloway,et al. TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo * , 2000, The Journal of Biological Chemistry.
[51] C. Overall,et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. , 2000, Science.
[52] Stephen J. Weiss,et al. Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3 , 2000, The Journal of cell biology.
[53] R. W. Rauser,et al. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[54] M A Moses,et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[55] Rongsong Li,et al. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. , 2000, Cancer research.
[56] G. Giannelli,et al. Role of Cell Surface Metalloprotease Mt1-Mmp in Epithelial Cell Migration over Laminin-5 , 2000, The Journal of cell biology.
[57] C. Lafuma,et al. Induction of Matrix Metalloproteinase MMP‐9 (92‐kDa Gelatinase) by Retinoic Acid in Human Neuroblastoma SKNBE Cells , 2000, Journal of neurochemistry.
[58] I. Stamenkovic,et al. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. , 2000, Genes & development.
[59] B. Fingleton,et al. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. , 2000, The Journal of clinical investigation.
[60] B. Fingleton,et al. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis , 1999, Current Biology.
[61] G. Karsenty. The genetic transformation of bone biology. , 1999, Genes & development.
[62] Qiwei Yang,et al. Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis. , 1999, American journal of physiology. Renal physiology.
[63] A. Albini,et al. Tumor invasion: molecular shears blunted by green tea , 1999, Nature Medicine.
[64] L. Matrisian,et al. Cancer biology: Extracellular proteinases in malignancy , 1999, Current Biology.
[65] J. Ward,et al. MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover , 1999, Cell.
[66] Z. Werb,et al. Matrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes , 1999, The Journal of Neuroscience.
[67] B. Nielsen,et al. Functional overlap between two classes of matrix‐degrading proteases in wound healing , 1999, The EMBO journal.
[68] S. Akiyama,et al. A Novel Protease-docking Function of Integrin at Invadopodia* , 1999, The Journal of Biological Chemistry.
[69] T. K. Hunt,et al. Impaired wound contraction in stromelysin-1-deficient mice. , 1999, Annals of surgery.
[70] Timo Sorsa,et al. Tumor targeting with a selective gelatinase inhibitor , 1999, Nature Biotechnology.
[71] D. Pinkel,et al. The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.
[72] T. K. Hunt,et al. Stromelysin-1-deficient fibroblasts display impaired contraction in vitro. , 1999, The Journal of surgical research.
[73] Napoleone Ferrara,et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.
[74] J. Baselga,et al. Cleavage of the HER2 ectodomain is a pervanadate-activable process that is inhibited by the tissue inhibitor of metalloproteases-1 in breast cancer cells. , 1999, Cancer research.
[75] C. Martínez-A,et al. The Matrix Metalloproteinase-9 Regulates the Insulin-like Growth Factor-triggered Autocrine Response in DU-145 Carcinoma Cells* , 1999, The Journal of Biological Chemistry.
[76] K. Nabeshima,et al. Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. , 1999, The American journal of pathology.
[77] I. Stamenkovic,et al. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. , 1999, Genes & development.
[78] R. Pierce,et al. Matrix metalloproteinases generate angiostatin: effects on neovascularization. , 1998, Journal of immunology.
[79] L. Matrisian,et al. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. , 1998, Cancer research.
[80] Tadej Battelino,et al. TGF-β Plays a Key Role in Morphogenesis of the Pancreatic Islets of Langerhans by Controlling the Activity of the Matrix Metalloproteinase MMP-2 , 1998, The Journal of cell biology.
[81] S. Weiss,et al. Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.
[82] P. Slocombe,et al. TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .
[83] P. Dempsey,et al. Tyrosine Phosphorylation and Proteolysis , 1998, The Journal of Biological Chemistry.
[84] W. Yu,et al. Requirement for Specific Proteases in Cancer Cell Intravasation as Revealed by a Novel Semiquantitative PCR-Based Assay , 1998, Cell.
[85] R. Cardiff,et al. CD44v3,8–10 is involved in cytoskeleton‐mediated tumor cell migration and matrix metalloproteinase (MMP‐9) association in metastatic breast cancer cells , 1998 .
[86] R. Iozzo. Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.
[87] Gabriele Bergers,et al. MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.
[88] R. Fridman,et al. High Affinity Binding of Latent Matrix Metalloproteinase-9 to the α2(IV) Chain of Collagen IV* , 1998, The Journal of Biological Chemistry.
[89] J. Foidart,et al. In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy , 1998, The Journal of cell biology.
[90] S. Itohara,et al. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. , 1998, Cancer research.
[91] D. Gomez,et al. Mammary carcinoma cells over‐expressing tissue inhibitor of metalloproteinases‐1show vascular endothelial growth factor expression , 1998 .
[92] M. Nomizu,et al. Activation of β1 Integrin Signaling Stimulates Tyrosine Phosphorylation of p190 RhoGAP and Membrane-protrusive Activities at Invadopodia* , 1998, The Journal of Biological Chemistry.
[93] J. Delaissé,et al. The Migration of Purified Osteoclasts Through Collagen Is Inhibited by Matrix Metalloproteinase Inhibitors , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[94] R. Cardiff,et al. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. , 1998, Journal of cellular physiology.
[95] D. Gomez,et al. Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression. , 1998, International journal of cancer.
[96] M. Klagsbrun,et al. Matrix Metalloproteinase-3 Releases Active Heparin-binding EGF-like Growth Factor by Cleavage at a Specific Juxtamembrane Site* , 1997, The Journal of Biological Chemistry.
[97] Z. Werb. ECM and Cell Surface Proteolysis: Regulating Cellular Ecology , 1997, Cell.
[98] R. Nagle,et al. Cleavage of β4 Integrin by Matrilysin , 1997 .
[99] M. Barbacid,et al. Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3* , 1997, The Journal of Biological Chemistry.
[100] D. Gomez,et al. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. , 1997, European journal of cell biology.
[101] L. Matrisian,et al. Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.
[102] S. Sheng,et al. Preparation and Characterization of Recombinant Tissue Inhibitor of Metalloproteinase 4 (TIMP-4)* , 1997, The Journal of Biological Chemistry.
[103] W. T. Chen,et al. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[104] G. Giannelli,et al. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. , 1997, Science.
[105] William C. Parks,et al. The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen Matrix , 1997, The Journal of cell biology.
[106] G. Trugnan,et al. Matrix Metalloproteinases MMP2 and MMP9 Are Produced in Early Stages of Kidney Morphogenesis but Only MMP9 Is Required for Renal Organogenesis In Vitro , 1997, The Journal of cell biology.
[107] I. Fidler,et al. Macrophage-Derived Metalloelastase Is Responsible for the Generation of Angiostatin in Lewis Lung Carcinoma , 1997, Cell.
[108] H. Nagase. Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.
[109] C. Lynch,et al. Role of the matrixin MMP-2 in multicellular organization of adipocytes cultured in basement membrane components. , 1997, The American journal of physiology.
[110] B. Hogan,et al. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[111] Z. Werb,et al. Metalloproteinases regulate parietal endoderm differentiating and migrating in cultured mouse embryos , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.
[112] B. Toole,et al. Stimulation of Matrix Metalloproteinase Production by Recombinant Extracellular Matrix Metalloproteinase Inducer from Transfected Chinese Hamster Ovary Cells* , 1997, The Journal of Biological Chemistry.
[113] H. Ohtani,et al. Stromal Expression of MMP‐9 and Urokinase Receptor Is Inversely Associated with Liver Metastasis and with Infiltrating Growth in Human Colorectal Cancer: A Novel Approach from Immune/Inflammatory Aspect , 1997, Japanese journal of cancer research : Gann.
[114] Z. Werb,et al. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene , 1996, The Journal of cell biology.
[115] R. Muschel,et al. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. , 1996, Cancer research.
[116] Y. Ma,et al. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[117] M. Flannery,et al. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. , 1996, Development.
[118] W. Stetler-Stevenson,et al. Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.
[119] John M. Whitelock,et al. The Degradation of Human Endothelial Cell-derived Perlecan and Release of Bound Basic Fibroblast Growth Factor by Stromelysin, Collagenase, Plasmin, and Heparanases (*) , 1996, The Journal of Biological Chemistry.
[120] L. Lund,et al. Impaired wound healing in mice with a disrupted plasminogen gene , 1996, Nature Medicine.
[121] Woessner Jf. Regulation of matrilysin in the rat uterus , 1996 .
[122] L. Coussens,et al. Matrix metalloproteinases and the development of cancer. , 1996, Chemistry & biology.
[123] W. Birchmeier,et al. Epithelial-mesenchymal transitions in cancer progression. , 1996, Acta anatomica.
[124] W. T. Chen,et al. Proteases associated with invadopodia, and their role in degradation of extracellular matrix. , 1996, Enzyme & protein.
[125] J. Woessner. Regulation of matrilysin in the rat uterus. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[126] Jack P. Witty,et al. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. , 1995, Molecular biology of the cell.
[127] Y. Okada,et al. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis , 1995, Molecular and cellular biology.
[128] J. Zimmermann,et al. Generation and activity of the ternary gelatinase B/TIMP-1/LMW-stromelysin-1 complex. , 1995, Biological chemistry Hoppe-Seyler.
[129] R. Jaenisch,et al. A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling , 1995, The Journal of cell biology.
[130] P. Reinemer,et al. The metzincins — Topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a super family of zinc‐peptidases , 1995, Protein science : a publication of the Protein Society.
[131] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[132] N. Rawlings,et al. Evolutionary families of metallopeptidases. , 1995, Methods in enzymology.
[133] A. Shinagawa,et al. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). , 1994, Journal of cell science.
[134] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[135] Z. Werb,et al. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752] , 1994, The Journal of cell biology.
[136] R. Timpl,et al. Molecular and Cellular Aspects of Basement Membranes , 1993 .
[137] A. Strongin,et al. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. , 1992, The Journal of biological chemistry.
[138] H. Birkedal‐Hansen,et al. Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian alpha-macroglobulins. , 1989, The Journal of biological chemistry.
[139] Y. Fukuda,et al. The role of interstitial collagens in cleft formation of mouse embryonic submandibular gland during initial branching. , 1988, Development.
[140] C. Lapière,et al. Collagenolytic activity in amphibian tissues: a tissue culture assay. , 1962, Proceedings of the National Academy of Sciences of the United States of America.